Skip to content

mCVI® Lighting Conditions Clinical Study

A Single-Center, Prospective Clinical Study to Demonstrate That in 4 Different Lighting Conditions mCVI® Accurately Captures Pulse Rate and Respiratory Rate in 10 Healthy Volunteers in Comparison to a Commercially-Available Masimo Pulse Oximeter Device

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04811300
Enrollment
9
Registered
2021-03-23
Start date
2021-04-09
Completion date
2021-05-15
Last updated
2021-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Algorithm Verification

Brief summary

This single center prospective clinical study is to verify the algorithm of mCVI® in 4 different lighting conditions to accurately capture pulse rate and respiratory rate in 10 healthy subjects in comparison to commercially-available Masimo pulse oximeter devices. This is a non significant risk device.

Detailed description

In this prospective clinical study the mCVI® device is a mobile application used to simply verify the algorithm when the mobile video reads a patients pulse rate and respiratory rate while spontaneously breathing. There is no facial recognition technology. There is no immediate feedback given to the research team to act upon or provide for further clinical care decisions. In real time, the mCVI® device will be compared to two commercially-available Masimo pulse oximeter devices in a single visit.

Interventions

OTHERThere is no intervention

There is no intervention

Sponsors

Intelomed, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
FAMILY_BASED
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults between the ages of 21 - 70 * Informed consent obtained and signed

Exclusion criteria

* Self-reported medical conditions that could compromise a participant's ability to provide for all breathing samples, pedal the Cubii Pro elliptical, or follow instructions * Self-reported medical history of respiratory or cardiovascular disease * Excessive facial hair, facial deformities, or obstructions (like glasses or face masks/shields) that could compromise the recording of pulse rate and respiratory rate of the mCVI® * Any face lotions or make up foundations that could compromise the recording of pulse rate and respiration rate of the mCVI® * Missing digits or fingers on one or more hand that would prevent proper recording of Masimo pulse oximeter devices * Participants wearing nail polish, acrylic nails, or rings on the ring finger of either hand that would prevent the proper use of Masimo pulse oximeter device * Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Pulse Rate Verification in Different Lighting Conditions2 monthsTo demonstrate that in 4 different lighting environments common to home and office/clinical conditions, mCVI® accurately captures pulse rate in comparison to Masimo pulse oximeter devices.
Respiration Rate Verification in Different Lighting Conditions2 monthsTo demonstrate that in 4 different lighting environments common to home and office/clinical conditions, mCVI® accurately captures respiratory rate in comparison to Masimo pulse oximeter devices.

Secondary

MeasureTime frameDescription
Skin Tone Pulse Rate Verification in Different Lighting Conditions2 monthsTo demonstrate that in 4 different lighting environments common to home and office/clinical conditions, mCVI® accurately captures pulse rate in healthy volunteers with a variety of skin tones using the Fitzpatrick Skin Type Scale.
Skin Tone Respiratory Rate Verification in Different Lighting Conditions2 monthsTo demonstrate that in 4 different lighting environments common to home and office/clinical conditions, mCVI® accurately captures respiration rates in healthy volunteers with a variety of skin tones using the Fitzpatrick Skin Type Scale.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026